ADARx Pharmaceuticals (ADRX) vs Kailera Therapeutics (KLRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Kailera Therapeutics is the larger company by market cap ($1.43 billion vs $1.42 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADRX | KLRA |
|---|---|---|
| Share price | $12.79 | $11.02 |
| Market cap | $1.42B | $1.43B |
| 1-day change | -9.68% | -4.84% |
| EPS (TTM) | $-6.75 | $-4.16 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $23.21 | $28.23 |
| 52-week low | $12.50 | $9.76 |
| Distance from 52-week high | -44.89% | -60.96% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +167.79% | +290.20% |
| Average volume | 650.63K | 1.08M |
| Shares outstanding | 111.19M | 129.85M |
| Employees | 100 | 145 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About ADARx Pharmaceuticals
ADRX stock →ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
About Kailera Therapeutics
KLRA stock →Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 145 employees
ADRX vs KLRA FAQ
Which is bigger, ADARx Pharmaceuticals or Kailera Therapeutics?
Kailera Therapeutics (KLRA) is larger, with a market capitalization of $1.43B compared with $1.42B for ADARx Pharmaceuticals (ADRX).
Are ADARx Pharmaceuticals and Kailera Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.